Triple-negative breast cancer is cancer that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. So, triple-negative breast cancer does not respond to hormonal therapy medicines or medicines that target HER2 protein receptors.
Doctors use many tests to find, or diagnose, breast cancer. . If the cancer is HER2 negative, HER2-targeted therapy is not a treatment option for you, and your.
Diagnosis of breast lump by fine needle aspiration cytology and mammography. cytology (FNAC) is being performed as a pre-operative test to evaluate breast lump. Mammography shows total 8 false positive and 5 false negative cases.